| Trisha Olson, | |
|
3883 74th Ave Ne, Fort Totten, ND 58335 | |
| (701) 766-1600 | |
| Not Available |
| Full Name | Trisha Olson |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 3883 74th Ave Ne, Fort Totten, North Dakota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912632704 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | R43304 (North Dakota) | Primary |
| Entity Name | Spirit Lake Tribe |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114472891 PECOS PAC ID: 2466550801 Enrollment ID: O20161206002392 |
News Archive
To measure anxiety in a mouse and suggest it's similar to anxiety in a person may seem like a stretch, but the metrics sound uncannily familiar.
With a relatively minor genetic change, a new treatment developed by researchers at the Georgia Institute of Technology and Emory University appears to stop replication of both flu viruses and the virus that causes Covid-19.
In its first decade, the GAVI Alliance has helped prevent the deaths of more than five million children by introducing more widespread vaccination in low-income countries, "[b]ut, going forward, the alliance is going to have to think more about getting parents to vaccinate their kids - the demand side of health - especially if it wants to repeat the huge victory of wiping out a disease" such as smallpox, Charles Kenny writes in his weekly column for Foreign Policy.
A significant number of Parkinson's disease patients have a mutation of the enzyme Leucine-Rich Repeat Protein Kinase 2 (LRRK2, also known as dardarin). However, little is understood about how it is regulated or functions. In a new paper in the Signal Knowledge Environment of the Biochemical Journal, Dario Alessi and colleagues from the University of Dundee demonstrate that a family of proteins, the 14-3-3 proteins, interact with LRRK2.
Raptor Pharmaceutical Corp. ("Raptor" or the "Company"), today announced the publication of results from a Phase 2a clinical trial of a prototype formulation of its proprietary delayed-release cysteamine bitartrate ("DR Cysteamine") in patients with nephropathic cystinosis ("cystinosis").
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Trisha Olson, 3883 74th Ave Ne, Fort Totten, ND 58335 Ph: () - | Trisha Olson, 3883 74th Ave Ne, Fort Totten, ND 58335 Ph: (701) 766-1600 |
News Archive
To measure anxiety in a mouse and suggest it's similar to anxiety in a person may seem like a stretch, but the metrics sound uncannily familiar.
With a relatively minor genetic change, a new treatment developed by researchers at the Georgia Institute of Technology and Emory University appears to stop replication of both flu viruses and the virus that causes Covid-19.
In its first decade, the GAVI Alliance has helped prevent the deaths of more than five million children by introducing more widespread vaccination in low-income countries, "[b]ut, going forward, the alliance is going to have to think more about getting parents to vaccinate their kids - the demand side of health - especially if it wants to repeat the huge victory of wiping out a disease" such as smallpox, Charles Kenny writes in his weekly column for Foreign Policy.
A significant number of Parkinson's disease patients have a mutation of the enzyme Leucine-Rich Repeat Protein Kinase 2 (LRRK2, also known as dardarin). However, little is understood about how it is regulated or functions. In a new paper in the Signal Knowledge Environment of the Biochemical Journal, Dario Alessi and colleagues from the University of Dundee demonstrate that a family of proteins, the 14-3-3 proteins, interact with LRRK2.
Raptor Pharmaceutical Corp. ("Raptor" or the "Company"), today announced the publication of results from a Phase 2a clinical trial of a prototype formulation of its proprietary delayed-release cysteamine bitartrate ("DR Cysteamine") in patients with nephropathic cystinosis ("cystinosis").
› Verified 7 days ago
Liza A Ystaas, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3883 74th Ave Ne, Fort Totten, ND 58335 Phone: 701-766-1600 | |
Mikkel Elizabeth Buckmier, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3883 74th Ave Ne, Fort Totten, ND 58335 Phone: 701-766-1600 | |
Cheryl A. Hefta, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 416 2nd Ave N, Fort Totten, ND 58335 Phone: 701-766-1251 Fax: 701-766-1260 | |
Kristen Renae Gourneau, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3883 74th Avenue, Fort Totten, ND 58335 Phone: 701-766-1600 | |
Macie Mikkelsen, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3883 74th Ave Ne, Fort Totten, ND 58335 Phone: 701-766-1600 | |
Worku Metaferia, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3883 74th Ave Ne, Fort Totten, ND 58335 Phone: 701-766-1600 | |
Kimberly Ann Brown, MSN, APRN, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3883 74th Ave Ne, Fort Totten, ND 58335 Phone: 701-766-1600 |